FDA Insight: The Opioid Epidemic and COVID-19 Pandemic | FDA

FDA Insight: The Opioid Epidemic and COVID-19 Pandemic | FDA

Join Dr. Anand Shah, FDA’s Deputy Commissioner for Medical and Scientific Affairs, and other FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics.

The Opioid Epidemic and COVID-19 Pandemic Dr. Shah welcomes Megan Moncur, FDA’s Associate Director of Opioid Policy, to the show to discuss the opioid epidemic and how it’s been impacted by the COVID-19 pandemic.